Singapore, July 21 -- Researchers from the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), have developed a swallowable nanoscale delivery platform designed to transport therapeutic enzymes through the stomach's acidic environment and activate a cancer-killing reaction at tumour sites.

Early preclinical findings suggest that the approach may offer a new strategy for treating gastric cancer more precisely while reducing damage to healthy tissue.

According to the Global Cancer Statistics, gastric cancer is the fifth most common cancer worldwide and the fourth leading cause of cancer-related death globally . It remains one of the hardest cancers to treat, as it is often found late, can spread quickly, and ...